Work

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

Year: 2017

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx232

Authors: A. Jatoi, P.D. Steen, P.J. Atherton, D.F. Moore, K.M. Rowland, N.A. Le-Lindqwister, C.S. Adonizio, A.J. Jaslowski, J. Sloan, C. Loprinzi

Institutions: Mayo Clinic, Sanford Health, Wichita Clinic, Carle Foundation Hospital, Geisinger Medical Center, St. Vincent Hospital

Language: English

Topic: Nutrition and Health in Aging

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute

Awards: Alliance NCORP Research Base, Carle Cancer Center NCI Community Oncology Research Program (NCORP)

OpenAlex ID: W2610831848

FWCI: 2.227

Cites: 23

Cited by: 38

Related to: 10